BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35091793)

  • 21. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
    Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
    Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
    Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
    J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MED12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC.
    Xu M; Wang F; Li G; Wang X; Fang X; Jin H; Chen Z; Zhang J; Fu L
    Mol Cancer; 2019 May; 18(1):93. PubMed ID: 31072327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RabGEF1 functions as an oncogene in U251 glioblastoma cells and is involved in regulating AKT and Erk pathways.
    Fan H; Xin T; Dong X; Yang F; Zhang R; Feng S; He D; Guo H; Pang Q
    Exp Mol Pathol; 2021 Feb; 118():104571. PubMed ID: 33166495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
    Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
    Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
    Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
    Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA.
    Shou J; Ali-Osman F; Multani AS; Pathak S; Fedi P; Srivenugopal KS
    Oncogene; 2002 Jan; 21(6):878-89. PubMed ID: 11840333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.
    Kämpjärvi K; Park MJ; Mehine M; Kim NH; Clark AD; Bützow R; Böhling T; Böhm J; Mecklin JP; Järvinen H; Tomlinson IP; van der Spuy ZM; Sjöberg J; Boyer TG; Vahteristo P
    Hum Mutat; 2014 Sep; 35(9):1136-41. PubMed ID: 24980722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
    Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
    J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The transcriptional regulator BCL6 participates in the secondary gene regulatory response to vitamin D.
    Nurminen V; Neme A; Ryynänen J; Heikkinen S; Seuter S; Carlberg C
    Biochim Biophys Acta; 2015 Mar; 1849(3):300-8. PubMed ID: 25482012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis.
    Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX
    Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.
    Albertoni M; Shaw PH; Nozaki M; Godard S; Tenan M; Hamou MF; Fairlie DW; Breit SN; Paralkar VM; de Tribolet N; Van Meir EG; Hegi ME
    Oncogene; 2002 Jun; 21(27):4212-9. PubMed ID: 12082608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ars2 promotes cell proliferation and tumorigenicity in glioblastoma through regulating miR-6798-3p.
    Chen Y; Hu X; Li Y; Zhang H; Fu R; Liu Y; Hu J; Deng Q; Luo Q; Zhang D; Gao N; Cui H
    Sci Rep; 2018 Oct; 8(1):15602. PubMed ID: 30349053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma.
    Wang CL; Wang JY; Liu ZY; Ma XM; Wang XW; Jin H; Zhang XP; Fu D; Hou LJ; Lu YC
    Carcinogenesis; 2014 Jul; 35(7):1500-9. PubMed ID: 24445145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
    Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
    Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: A clinicopathologic study.
    Romano FJ; Guadagno E; Solari D; Borrelli G; Pignatiello S; Cappabianca P; Del Basso De Caro M
    J Cell Biochem; 2018 Jun; 119(6):4867-4877. PubMed ID: 29369420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.